News

Pathway identified which affects stress-induced lipid metabolism, implicates epigenetic dysregulation in relevant human diseases.

New method increases the released lentiviral particles produced by host cells, which will aid the use of the vectors for introducing foreign genes.

As Halloween revelers prepare to feast on chocolate, a new study is pushing back the origins of the delicious sweet treat.

A kill code is embedded in every cell in the body whose function may be to cause the self-destruction of cells that become cancerous, reports a new Northwestern Medicine study.

A screening pipeline capable of detecting interactions within protein libraries or between protein libraries and RNA fragment pools has been developed to improve understanding of cellular mechanisms.

Aequatus - a new bioinformatics tool developed at Earlham Institute (EI) - is helping to give an in-depth view of syntenic information between different species, providing a system to better identify important, positively-selected, and evolutionarily-conserved regions of DNA.

The intricate quest to discover where tetracyclines go in human cells is over, helping to understand the promising results shown in their use to treat pathological inflammation and cancer.

The chemical company BASF has attained a global, non-exclusive licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cpf1 genome editing technology to improve products in agricultural and industrial microbiology applications.

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new clinical trial results.

Researchers have discovered that inhibiting CDK9, a DNA transcription regulator, reactivates genes that have been epigenetically silenced by cancer.